Quantcast
Channel: Endpoints News
Viewing all articles
Browse latest Browse all 3652

Argenx’s Vyvgart Hytrulo syringe is approved in the US; Opthea to cut 65% of staff

$
0
0
Plus, news about Protagonist Therapeutics, Pfizer and Keros Therapeutics: Argenx wins FDA approval for Vyvgart Hytrulo syringe: The subcutaneous injection, which comes in a more convenient prefilled syringe, can be self-administered by the patient. Vyvgart ...

Viewing all articles
Browse latest Browse all 3652

Trending Articles